Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-01 6:09 pm Unchanged | 13G | KALA PHARMACEUTICALS INC KALA | ORBIMED ADVISORS LLC | 4,714,195 8.41% | 0 (Unchanged) | View |
| 2021-02-12 4:53 pm Purchase | 13G | KALA PHARMACEUTICALS INC KALA | ORBIMED ADVISORS LLC | 4,714,195 8.41% | 1,266,355 (+36.73%) | View |
| 2021-02-12 4:08 pm Purchase | 13G | KALA PHARMACEUTICALS INC KALA | EVENTIDE ASSET MANAGEMENT LLC | 3,450,000 6.2% | 3,450,000 (New Position) | View |
| 2021-02-02 3:13 pm Purchase | 13G | KALA PHARMACEUTICALS INC KALA | BlackRock Inc. BLK | 3,160,506 5.6% | 3,160,506 (New Position) | View |
| 2020-03-23 5:00 pm Purchase | 13D | KALA PHARMACEUTICALS INC KALA | Longitude Capital Partners II LLC | 5,457,030 10% | 2,561,664 (+88.47%) | View |
| 2020-03-13 5:19 pm Purchase | 13D | KALA PHARMACEUTICALS INC KALA | RA CAPITAL MANAGEMENT L.P. | 10,874,613 19.9% | 6,337,135 (+139.66%) | View |
| 2020-02-12 4:55 pm Sale | 13G | KALA PHARMACEUTICALS INC KALA | Polaris Venture Partners V L.P. | 598,620 1.7% | -1,292,293 (-68.34%) | View |